Clinical Trial

Screening for Intrapartum Fetal Compromise Using Placental Biomarkers

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate the association between placental markers (sFlt-1, PlGF, and the sFlt-1/PlGF ratio) and intrapartum fetal compromise, assessed on the basis of the cardiotocographic tracing.
Trial Details
NCT Number NCT07258329
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Pregnant Women
Enrollment 428 participants
Start Date 2025-03-28
Primary Completion 2028-02-01 (estimated)
Study Completion 2028-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-02